Time schedule of the study and the publication of the study results

‚Äč

Recruitment of the patients will commence during 2019 and will last until the calculated sample size has been reached. It is estimated that patient recruitment will last at most 2 years. Thus, the follow up of the patients is estimated to last until the end of 2022. The results will be analyzed during the year of 2022-2023 and the results are estimated to be published before the end of 2023. Due to the significant clinical importance of this study the results will be sent for publication to a cardiovascular journal of high scientific impact.

This project has received funding from the European Union's Horizon 2020 research and innovation progamme under grant agreement No 731532.

©2020 by ReGenHeart